Actuate Therapeutics to Participate in Upcoming Investor Conferences in February
BIO CEO & Investor Conference Format: "IPO Class of 2024 Panel" and one-on-one meetings Date: February 10, 2025 Location: New York, NY Registered conference attendees may schedule one-on-one meetings ...
tech-ish.com4h
Kenya Pipeline Company Eyes NSE Listing
Kenya Pipeline Company plans NSE listing to expand, boost liquidity, enhance regional presence, and improve financial sustainability and governance.
PharmiWeb12h
BIOVERSYS SUCCESSFULLY COMPLETES ITS IPO AT CHF 36…
IPOBIOVERSYS SUCCESSFULLY COMPLETES ITS IPO AT CHF 36 PER SHARE AND STARTS TRADING ON THE SIX SWISS EXCHANGE TOMORROW, FEBRUARY 07, 2025 06.02.2025 / 07:00 CET/CEST__________THIS IS A RESTRICTED ...
inc424h
INR 2,500 Cr Revenue, IPO In Motion: How Razorpay Is Prepping For D-Street
IPO-bound Razorpay CEO Harshil Mathur on what it took to get the fintech giant ready for the public listing - from governance ...
Hillenbrand projects $685M-$705M Q2 revenue with focus on deleveraging and portfolio transformation
Hillenbrand anticipates Q2 revenue in the range of $685 million to $705 million and adjusted EPS between $0.53 and $0.58. Full-year guidance has been updated to reflect the Milacron transaction, ...
The Hershey Company (HSY) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call February 6, 2025 8:30 AM ETCompany ParticipantsAnoori Naughton - Senior Director of ...
Budget amendment limiting carry forward of losses can make distressed deals less attractive, say experts
A Budget 2025 amendment that proposes to limit carrying forward of business losses to up to eight years from the period of ...